90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
Autor: | Morschhauser, Franck, Radford, John, Van Hoof, Achiel, Botto, Barbara, Rohatiner, Ama Z S, Salles, Gilles, Soubeyran, Pierre, Tilly, Herve, Bischof-Delaloye, Angelika, van Putten, Wim L J, Kylstra, Jelle W, Hagenbeek, Anton |
---|---|
Zdroj: | Journal of Clinical Oncology; 6/1/2013, Vol. 31 Issue 16, p1977-1983, 7p |
Databáze: | Supplemental Index |
Externí odkaz: |